The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Halozyme Retains TCG to Secure Clinical Team

February 9, 2016
The Chase Group has been retained by Halozyme Therapeutics to partner with Dr. Dimitrios Chondros as he builds his clinical team. Halozyme is a clinical stage biotechnology company focused on developing and commercializing novel cancer therapies that target the tumor microenvironment.

Chase Group

Share This News Post

© Copyright 1993-2022 The Chase Group; All Rights Reserved.